Symptoms and recovery after COVID-19 vaccine
Part of Bones, joints & muscles, Brain & nervous system clinical trials.
This study looks at people who developed new, long-lasting symptoms after a COVID-19 vaccine. It aims to understand their symptoms, do lab tests, and see how they recover over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You need to speak German well enough to fill out questionnaires.
- Your symptoms began within 2 weeks after a COVID-19 vaccine.
- Your symptoms have lasted for at least 6 months.
- You cannot have had a known COVID-19 infection around the time your symptoms started.
- Your symptoms cannot be explained by another existing condition, such as ME/CFS, fibromyalgia, or an autoimmune disease.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a treatment that targets metabolism to help people with long-term fatigue that started within two weeks of a COVID-19 vaccine.
This study looks at how COVID-19 changes your genes, which might explain why some people have long-lasting symptoms. If you join, you'll provide a blood sample, and the results could help us better understand long COVID.
This study follows adults who recently recovered from COVID-19 to better understand what happens during recovery and afterward. It may help researchers identify who is at risk for longer-lasting symptoms (often called “PASC”) and what changes over time.
This trial is testing treatments for people with long COVID, which is when symptoms last more than 3 months after a COVID-19 infection. The trial focuses on three specific symptom groups: heart inflammation, cough, or severe fatigue with signs of inflammation. It aims to find if certain immune-modulating therapies can help.
This study looks for signs of leftover SARS-CoV-2 virus in people who have fully recovered from COVID-19, including those with ongoing neurological symptoms (like brain fog, fatigue, or nerve pain). It aims to understand why some people have long-lasting symptoms after infection.
This study compares the blood of people with ongoing long COVID symptoms to healthy people, to look for differences in immune signals and gut bacteria. It could help find better ways to diagnose or treat long COVID.
Hear when a new Post-Acute COVID-19 Vaccination Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.